Explore
← New search
Filters:
North America
✕
1
✕
cog p9906 high-risk b-all patient cohort (n=207 total, n=15/n=14 subgroups)
✕
clear all
1 matching publication(s)
Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic l
PMID 37217248 · J Immunother Cancer · 2023
L1
76/100